Literature DB >> 20526096

Biology of colorectal cancer.

Muhammad Wasif Saif1, Edward Chu.   

Abstract

Significant advances have been made in understanding the biology of colorectal cancer. In this chapter, we review the key signaling pathways that play key roles in maintaining the growth and proliferation of colorectal cancer. The pathways that will be discussed include Wnt/beta-catenin, TGF-beta/SMAD, Notch, Hedgehog, epidermal growth factor receptor, Ras, and PI3K/Akt. In addition, we review the growing role of colon cancer stem cells in mediating cellular drug resistance and cancer recurrence. This enhanced understanding of cancer biology provides important insights for developing novel therapies that target specific growth factor receptors and/or certain critical signal transduction pathways. These targeted therapies can then be used alone or in combination with standard cytotoxic chemotherapy regimens.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20526096     DOI: 10.1097/PPO.0b013e3181e076af

Source DB:  PubMed          Journal:  Cancer J        ISSN: 1528-9117            Impact factor:   3.360


  57 in total

1.  Peroxisome proliferator-activated receptor-γ is downregulated in ulcerative colitis and is involved in experimental colitis-associated neoplasia.

Authors:  Xiaotan Dou; Junhua Xiao; Ziliang Jin; Ping Zheng
Journal:  Oncol Lett       Date:  2015-06-19       Impact factor: 2.967

2.  Increased EZH2 expression during the adenoma-carcinoma sequence in colorectal cancer.

Authors:  Mayuko Ohuchi; Yasuo Sakamoto; Ryuma Tokunaga; Yuki Kiyozumi; Kenichi Nakamura; Daisuke Izumi; Keisuke Kosumi; Kazuto Harada; Junji Kurashige; Masaaki Iwatsuki; Yoshifumi Baba; Yuji Miyamoto; Naoya Yoshida; Takashi Shono; Hideaki Naoe; Yutaka Sasaki; Hideo Baba
Journal:  Oncol Lett       Date:  2018-07-31       Impact factor: 2.967

3.  CBB1003, a lysine-specific demethylase 1 inhibitor, suppresses colorectal cancer cells growth through down-regulation of leucine-rich repeat-containing G-protein-coupled receptor 5 expression.

Authors:  Hung-Chih Hsu; Yi-Shiuan Liu; Kai-Chi Tseng; Tsai-Sheng Yang; Chien-Yuh Yeh; Jeng-Fu You; Hsin-Yuan Hung; Shu-Jen Chen; Hua-Chien Chen
Journal:  J Cancer Res Clin Oncol       Date:  2014-07-25       Impact factor: 4.553

4.  Novel diet-related mouse model of colon cancer parallels human colon cancer.

Authors:  Anil R Prasad; Shilpa Prasad; Huy Nguyen; Alexander Facista; Cristy Lewis; Beryl Zaitlin; Harris Bernstein; Carol Bernstein
Journal:  World J Gastrointest Oncol       Date:  2014-07-15

Review 5.  Update on Sporadic Colorectal Cancer Genetics.

Authors:  Karin M Hardiman
Journal:  Clin Colon Rectal Surg       Date:  2018-04-01

Review 6.  Prospective of colon cancer treatments and scope for combinatorial approach to enhanced cancer cell apoptosis.

Authors:  Jayshree Mishra; Joseph Drummond; Sohel H Quazi; Satya Sridhar Karanki; J J Shaw; Ben Chen; Narendra Kumar
Journal:  Crit Rev Oncol Hematol       Date:  2012-10-23       Impact factor: 6.312

7.  Diamond-lipid hybrids enhance chemotherapeutic tolerance and mediate tumor regression.

Authors:  Laura K Moore; Edward K Chow; Eiji Osawa; J Michael Bishop; Dean Ho
Journal:  Adv Mater       Date:  2013-04-15       Impact factor: 30.849

8.  The dietary bioflavonoid quercetin synergizes with epigallocathechin gallate (EGCG) to inhibit prostate cancer stem cell characteristics, invasion, migration and epithelial-mesenchymal transition.

Authors:  Su-Ni Tang; Chandan Singh; Dara Nall; Daniel Meeker; Sharmila Shankar; Rakesh K Srivastava
Journal:  J Mol Signal       Date:  2010-08-18

Review 9.  Resveratrol and clinical trials: the crossroad from in vitro studies to human evidence.

Authors:  Joao Tomé-Carneiro; Mar Larrosa; Antonio González-Sarrías; Francisco A Tomás-Barberán; María Teresa García-Conesa; Juan Carlos Espín
Journal:  Curr Pharm Des       Date:  2013       Impact factor: 3.116

10.  Endothelial cells promote the colorectal cancer stem cell phenotype through a soluble form of Jagged-1.

Authors:  Jia Lu; Xiangcang Ye; Fan Fan; Ling Xia; Rajat Bhattacharya; Seth Bellister; Federico Tozzi; Eric Sceusi; Yunfei Zhou; Isamu Tachibana; Dipen M Maru; David H Hawke; Janusz Rak; Sendurai A Mani; Patrick Zweidler-McKay; Lee M Ellis
Journal:  Cancer Cell       Date:  2013-01-31       Impact factor: 31.743

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.